Terpyridines and their complexes with first row transition metal ions: Cytotoxicity, nuclease activity and self-assembly of Biomacromolecules

Current Topics in Medicinal Chemistry

Volumn 12, Issue 3, 2012, Pages 158-175

  Winter, Andreas ^a,b   Gottschaldt, Michael ^a,b   Newkome, George R ^c   Schubert, Ulrich S ^a,b,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Jena Center for Soft Matter JCSM   (Germany)

^c UNIVERSITY OF AKRON   (United States)

^d DUTCH POLYMER INSTITUTE DPI   (Netherlands)

Author keywords

Cytotoxicity; DNA cleavage; Metallodrugs; Self assembly; Supramolecular chemistry; Terpyridine complexes

Indexed keywords

ANTINEOPLASTIC AGENT; IRON; NUCLEASE; NUCLEIC ACID; PYRIDINE DERIVATIVE; TERPYRIDINE; TRANSITION ELEMENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CELL STRAIN HEPG2; CELL STRAIN MCF 7; COMPLEX FORMATION; CYTOTOXICITY; ENZYME ACTIVITY; EVALUATION; HELA CELL; HUMAN; IC 50;

ANTINEOPLASTIC AGENTS; COORDINATION COMPLEXES; CYTOTOXINS; ENDONUCLEASES; IONS; LIGANDS; MOLECULAR PROBES; PYRIDINES; TRANSITION ELEMENTS;

EID: 84856433874     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612799078919     Document Type: Article

References (128)

1. Storr, T.; Thompson, K. H.; Orvig, C. Design of targeting ligands in medicinal inorganic chemistry. Chem. Soc. Rev., 2006, 35(6), 534-544.
2. Rosenberg, B.; Vancamp, L.; Trosko, J. E.; Mansour, V. H. Platinum compounds: a new class of potent antitumour agents. Nature, 1969, 222(5191), 385-386.
3. Sleijfer, D. T.; Meijer, S.; Mulder, N. H. Cisplatin: a review of clinical applications and renal toxicity. Pharm. World Sci., 1985, 7(6), 237-244.
4. Boulikas, T.; Vougiouka, M. Cisplatin and platinum drugs at the molecular level. Oncol. Rep., 2003, 10(6), 1663-1682.
5. Guo, Z.-J.; Sadler, P. J. Metals in medicine. Angew. Chem. Int. Ed., 1999, 38(11), 1512-1531.
6. Thompson, K. H.; Orvig, C. Boon and bane of metal ions in medicine. Science, 2003, 300(5621), 936-939.
7. Thompson, K. H.; Orvig, C. In Concepts and Models in Bioinorganic Chemistry; Kraatz, H.-B., Metzler-Nolte, N., Eds.; Wiley-VCH: Weinheim, 2006; pp 25-46.
8. Salvemini, D.; Riley, D. P.; Cuzzocrea, S. Sod mimetics are coming of age. Nat. Rev. Drug Discov., 2002, 1(5), 367-374.
9. Thomas, C. M.; Ward, T. R. Artificial metalloenzymes: proteins as hosts for enantioselective catalysis. Chem. Soc. Rev., 2005, 34(4), 337-346.
10. Winkler, J. R.; Gray, H. B. jr. Electron transfer in rutheniummodified proteins. Chem. Rev., 1992, 92(3), 369-379.
11. Erkkila, K. E.; Odom, D. T.; Barton, J. K. Recognition and reaction of metallointercalators with DNA. Chem. Rev., 1999, 99(9), 2777-2796.
12. McLendon, G. Long-distance electron transfer in proteins and model systems. Acc. Chem. Res., 1988, 21(4), 160-167.
13. Beilstein, A. E.; Tierney, M. T.; Grinstaff, M. W. Site-specifically labeled metallo-oligodeoxynucleotides. Comments Inorg. Chem., 2000, 22(1-2), 105-127.
14. Lakowicz, J. R.; Gryczynski, I.; Piszczek, G.; Tolosa, L.; Nair, R.; Johnson, M. L.; Nowaczyk, K. Microsecond dynamics of biological macromolecules. Methods Enzymol., 2000, 323(1-2), 473-509.
15. Reed, E. Cisplatin. Cancer Chemother. Biol. Response Modif., 1999, 18(1), 144-151.
16. Trimmer, E. E.; Essigmann, J. M. Cisplatin. Essays Biochem., 1999, 34(191-211.
17. Platinum-Based Drugs in Cancer Therapy; Kelland, L. R.; Farrell, N. P., Eds.; Humana Press: New Jersey, 2000.
18. Harper, B. W.; Krause-Heuer, A. M.; Grant, M. P.; Manohar, M.; Garbutcheon-Singh, K. B.; Aldrich-Wright, J. R. Advances in Platinum Chemotherapeutics. Chem. Eur. J., 2010, 16(24), 7064-7077.
19. Lerman, L. S. Structural considerations in the interaction of DNA and acridines. J. Mol. Biolol., 1961, 3(1), 18-30.
20. Jennette, K. W.; Lippard, S. J.; Vassiliades, G. A.; Bauer, W. R. Metallointercalation reagents: 2-hydroxyethanethiolato(2,2':6',2'-terpyridine)platinum(II) monocation binds strongly to DNA by intercalation. Proc. Natl. Acad. Sci. USA, 1974, 71(10), 3839-3843.
21. Gottschaldt, M.; Schubert, U. S. Prospects of metal complexes peripherally substituted with sugars in biomedicinal applications. Chem. Eur. J., 2009, 15(7), 1548-1557.
22. Lippard, S. J. Platinum complexes: probes of polynucleotide structure and antitumor drugs. Acc. Chem. Res., 1978, 11(5), 211-217.
23. Van Vliet, P. M.; Toekimin, S. M. S.; Haasnoot, J. G.; Reedijk, J.; Nováková, O.; Vrána, O.; Brabec, V. Mer-[Ru(terpy)Cl3] (terpy =2,2':6',2'-terpyridine) shows biological activity, forms interstrand cross-links in DNA and binds two guanine derivatives in a transconfiguration. Inorg. Chim. Acta, 1995, 231(1-2), 57-64.
24. Eryazici, I.; Moorefield, C. N.; Newkome, G. R. Square-planar Pd(II), Pt(II), and Au(III) terpyridine complexes: their syntheses, physical properties, supramolecular constructs, and biomedical activities. Chem. Rev., 2008, 108(6), 1834-1895.
25. Satyanarayana, S.; Dabrowiak, J. C.; Chaires, J. B. Neither D-nor L-tris(phenanthroline)ruthenium(II) binds to DNA by classical intercalation. Chem. Rev., 1992, 31(39), 9319-9324.
26. Brabec, V.; Nováková, O. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Drug Resist. Updates, 2006, 9(3), 111-122.
27. Brabec, V. DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. Prog. Nucleic Acid Res. Mol. Biol., 2002, 71(1), 1-68.
28. Schubert, U. S.; Hofmeier, H.; Newkome, G. R. Modern Terpyridine Chemistry; Wiley-VCH: Weinheim, 2006.
29. Ulbricht, C.; Beyer, B.; Friebe, C.; Winter, A.; Schubert, U. S. Recent developments in the application of phosphorescent iridium(III) complex systems. Adv. Mater, 2009, 21(44), 4418-4441.
30. Kim, D. S. H. L.; Ashendel, C. L.; Zhou, Q.; Chang, C.-T.; Lee, E.-S.; Chang, C.-J. Novel protein kinase C inhibitors: α-terthiophene derivatives. Bioorg. Med. Chem. Lett., 1998, 8(19), 2695-2698.
31. Xu, W.-C.; Zhou, Q.; Ashendel, C. L.; Chang, C.-T.; Chang, C.-J. Novel protein kinase C inhibitors: synthesis and PKC inhibition of β-substituted polythiophene derivatives. Bioorg. Med. Chem. Lett., 1999, 9(15), 2279-2282.
32. Zhao, L.-X.; Kim, T.-S.; Ahn, S.-H.; Kim, T.-H.; Kim, E.-K.; Cho, W.-J.; Choi, H.; Lee, C.-S.; Kim, J.-A.; Jeong, T.-C.; Chang, C.-J.; Lee, E.-S. Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2':6',2'-, 2,2':6',3'-and 2,2':6',4'-terpyridine derivatives. Bioorg. Med. Chem. Lett., 2001, 11(19), 2659-2662.
33. Schubert, U. S.; Winter, A.; Newkome, G. R. Terpyridine Based Materials: For Catalytic, Optoelectronic and Lifescience Applications; Wiley-VCH: Weinheim, 2011.
34. Venkataraman, D. Y. D.; Wilson, S. B.; Hirsch, K. A.; Zhang, P.; Moore, J. S. A coordination geometry table of the d-block elements and their ions. J. Chem. Educ., 1997, 74(8), 915.
35. Holyer, R. H.; Hubbard, C. D.; Kettle, S. F. A.; Wilkins, R. G. The kinetics of replacement reactions of complexes of the transition metals with 2,2',2-terpyridine. Inorg. Chem., 1966, 5(4), 622-625.
36. Dobrawa, R.; Ballester, P.; Saha-Möller, C. R.; Würthner, F. In Metal-Containing and Metallosupramolecular Polymers and Materials; Schubert, U. S., Newkome, G. R., Manners, I., Eds.; ACS Publishing: Washington D.C., 2006; Vol. 928; pp 43-62.
37. Cowan, J. A. Chemical nucleases. Curr. Opin. Chem. Biol., 2001, 5(6), 634-642.
38. Routier, S.; Bernier, J.-L.; Waring, M. J.; Colson, P.; Houssier, C.; Bailly, C. Synthesis of a functionalized salen-copper complex and its interaction with DNA. Synthesis of a functionalized salencopper complex and its interaction with DNA, 1996, 61(7), 2326-2331.
39. Gravert, D. J.; Griffin, J. H. In Metal Ions in Biological Systems; Sigel, A., Sigel, H., Eds.; Marcel Dekker Inc.: New York, 1996; Vol. 33; pp 515-536.
40. Bhattacharya, S.; Mandal, S. S. Ambient oxygen activating water soluble cobalt-salen complex for DNA cleavage. J. Chem. Soc. Chem. Commun., 1995, (24), 2489-2490.
41. Muller, J. G.; Kayser, L. A.; Paikoff, S. J.; Duarte, V.; Tang, N.; Perez, R. J.; Rokita, S. E.; Burrows, C. J. Formation of DNA adducts using nickel(II) complexes of redox-active ligands: a comparison of salen and peptide complexes. Coord. Chem. Rev., 1999, 185-186(1), 761-774.
42. Maret, W. Zinc biochemistry, physiology, and homeostasis - recent insights and current trends. Biometals, 2001, 14(3-4), 187-190.
43. Walkup, G. K.; Burdette, S. C.; Lippard, S. J.; Tsien, R. Y. A new cell-permeable fluorescent probe for Zn2+. J. Am. Chem. Soc., 2000, 122(23), 5644-5645.
44. Franklin, R. B.; Costello, L. C. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch. Biochem. Biophys., 2007, 463(2), 211-217.
45. Nakayama, A.; Hiromura, M.; Adachi, Y.; Sakurai, H. Molecular mechanism of antidiabetic zinc-allixin complexes: regulations of glucose utilization and lipid metabolism. J. Biol. Inorg. Chem., 2008, 13(5), 675-684.
46. Golovine, K.; Makov, P.; Uzzo, R. G.; Shaw, T.; Kunkle, D.; Kolenko, V. M. Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-κB and reduces the malignant potential of prostate cancer cells in vitro and in vivo. Clin. Cancer Res., 2008, 14(17), 5376-5384.
47. Zhao, R.; Planalp, R. P.; Ma, R.; Greene, B. T.; Jones, B. T.; Brechbiel, M. W.; Torti, F. M.; Torti, S. V. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Biochem. Pharmacol., 2004, 67(9), 1677-1688.
48. Jiang, Q.; Zhu, J.-H.; Zhang, Y.-M.; Xiao, N.; Guo, Z.-J. DNA binding property, nuclease activity and cytotoxicity of Zn(II) complexes of terpyridine derivatives. Biometals 2009, 22(2), 297-305.
49. Ma, Z.; Cao, Y.-Q.; Li, Q.-S.; Guedes da Silva, M. F.; Fraústo da Silva, J. J. R.; Pombeiro, A. J. L. Synthesis, characterization, solidstate photo-luminescence and anti-tumor activity of zinc(II) 4'-phenyl-terpyridine compounds. J. Inorg. Biochem., 2010, 104(7), 704-711.
50. Kwong, H.-L.; Wong, W.-L.; Lee, C.-S.; Yeung, C.-T.; Teng, P.-F. Zinc(II) complex of terpyridine-crown macrocycle: a new motif in fluorescence sensing of zwitterionic amino acids. Inorg. Chem. Commun., 2009, 12(9), 815-818.
51. Kovala-Demertzi, D.; Alexandratos, A.; Papageorgiou, A.; Nath Yadav, P.; Dalezis, P.; Demertzis, M. A. Synthesis, characterization, crystal structures, in vitro and in vivo antitumor activity of palladium(II) and zinc(II) complexes with 2-formyl and 2-acetyl pyridine N4-1-(2-pyridyl)-piperazinyl thiosemicarbazone. Polyhedron, 2008, 27(13), 2731-2738.
52. Kong, D.-Y.; Xie, Y.-Y. Synthesis, structural characterization of tetraazamacrocyclic ligand, five-coordinated zinc(II) complex. Inorg. Chim. Acta. 2002, 338(1), 142-148.
53. Bertrand, H.; Monchaud, D.; De Cian, A.; Guillot, R.; Mergny, J.-L.; Teulade-Fichou, M.-P. The importance of metal geometry in the recognition of G-quadruplex-DNA by metal-terpyridine complexes. Org. Biomol. Chem. 2005, 3(16), 2555-2559.
54. Bertrand, H.; Sombard, S.; Monchaud, D.; Talbot, E.; Guedin, A.; Mergny, J.-L.; Grunert, R.; Bednarski, P. J.; Teulade-Fichou, M.-P. Exclusive platination of loop adenines in the human telomeric Gquadruplex. Org. Biomol. Chem. 2009, 7(14), 2864-2871.
55. May, P. M.; Williams, D. R. In Metal Ions in Biological Systems; Sigel, H., Sigel, A., Eds.; Marcel Dekker: New York, 1981; Vol. 12; pp 283-317.
56. Metal Ions in Biological Systems; Sigel, A.; Sigel, H., Eds.; Marcel Dekker: New York, 1931; Vol. 13.
57. Miura, T.; Hori-i, A.; Mototani, H.; Takeuchi, H. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence. Biochemistry, 1999, 38(35), 11560-11569.
58. Barton, J. K. In Bioinorganic Chemistry; Bertini, I., Gray, H. B., Lippard, S. J., Valentine, J. S., Eds.; University Science Books: Mill Valley, 1994; pp 455-504.
59. Linkletter, B.; Chin, J. Rapid hydrolysis of RNA with a CuII complex. Angew. Chem. Int. Ed., 1995, 34(4), 472-474.
60. Sigman, D. S.; Graham, D. R.; D'Aurora, V.; Stern, A. M. Oxygendependent cleavage of DNA by the 1,10-phenanthroline-cuprous complex: inhibition of Escherichia coli DNA polymerase I. J. Biol. Chem., 1979, 254(24), 12269-12272.
61. Dhar, S.; Chakravarty, A. R. Efficient visible light induced nuclease activity of a ternary mono-1,10-phenanthroline copper(II) complex containing 2-(methylthio)ethylsalicylaldimine. Inorg. Chem., 2003, 42(8), 2483-2485.
62. García-Raso, Á.; Fiol, J. J.; Adrover, B.; Moreno, V.; Mata, I.; Espinosa, E.; Molins, E. Synthesis, structure and nuclease properties of several ternary copper(II) peptide complexes with 1,10-phenanthroline. J. Inorg. Biochem., 2002, 95(2-3), 77-86.
63. Lu, L.-P.; Zhu, M.-L.; Shimizu, T. Crystal structure and nuclease activity of mono(1,10-phenanthroline) copper complex J. Inorg. Biochem., 2003, 95(1), 31-36.
64. Hemmert, C.; Pietié, M.; Renz, M.; Gornitzka, H.; Soulet, S. Preparation, characterization and crystal structures of manganese(II), iron(III) and copper(II) complexes of the bis[di-1,1-(2-pyridyl)ethyl]amine (BDPEA) ligand; evaluation of their DNA cleavage activities. J. Biol. Inorg. Chem., 2001, 6(1), 14-22.
65. Meijler, M. M.; Zelenko, O.; Sigman, D. S. Chemical mechanism of DNA scission by (1,10-phenanthroline)copper: carbonyl oxygen of 5-methylenefuranone is derived from water. J. Am. Chem. Soc., 1997, 119(5), 1135-1136.
66. Ross, S. A.; Pietié, M.; Meunier, B. Synthesis of two acridine conjugates of the bis(phenanthroline) ligand "clip-phen" and evaluation of the nuclease activity of the corresponding copper complexes. Eur. J. Inorg. Chem., 1999, (3), 557-563.
67. Baudoin, O.; Teulade-Fichou, M.-P.; Vigneron, J.-P.; Lehn, J.-M. Efficient copper(II)-mediated nuclease activity of orthoquinacridines. Chem. Commun., 1998, (21), 2349-2350.
68. Kuwabara, M. D.; Yoon, C.; Goyne, T.; Thederahn, T. B.; Sigman, D. S. Nuclease activity of 1,10-phenanthroline-copper ion: reaction with CGCGAATTCGCG and its complexes with netropsin and EcoRI. Biochemistry, 1986, 25(23), 7401-7408.
69. Thederahn, T. B.; Spassky, A.; Kuwabara, M. D.; Sigman, D. S. Chemical nuclease activity of 5-phenyl-1,10-phenanthroline-copper ion detects intermediates in transcription initiation by E. Coli RNA polymerase. Biochem. Biophys. Res. Commun., 1990, 168(2), 756-762.
70. Vaidyanathan, V. G.; Nair, B. U. Oxidative cleavage of DNA by a tridentate copper(II) complex. J. Inorg. Biochem., 2003, 93(3-4), 271-276.
71. Wang, X.-L.; Chao, H.; Li, H.; Hong, X.-L.; Ji, L.-N.; Li, X.-Y. Synthesis, crystal structure and DNA cleavage activities of copper(II) complexes with asymmetric tridentate ligands. J. Inorg. Biochem., 2004, 98(3), 423-429.
72. Carter, M. T.; Rodriguez, M.; Bard, A. J. Voltammetric studies of the interaction of metal chelates with DNA: tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2'-bipyridine. J. Am. Chem. Soc., 1989, 111(24), 8901-8911.
73. Chao, H.; Mei, W.-J.; Huang, Q.-W.; Ji, L.-N. DNA binding studies of ruthenium(II) complexes containing asymmetric tridentate ligands. J. Inorg. Biochem., 2002, 92(3-4), 165-170.
74. Uma, V.; Kanthimathi, M.; Weyhermüller, T.; Nair, B. U. Oxidative DNA cleavage mediated by a new copper(II) terpyridine complex: crystal structure and DNA binding studies. J. Inorg. Biochem., 2005, 99(12), 2299-2307.
75. Uma, V.; Vaidyanathan, V. G.; Nair, B. U. Synthesis, structure, and DNA binding studies of copper(II) complexes of terpyridine derivatives. Bull. Chem. Soc. Jpn., 2005, 78(5), 845-850.
76. Sreedhara, A.; Cowan, J. A. Efficient catalytic cleavage of DNA mediated by metalloaminoglycosides. Chem. Commun., 1998, (16), 1737-1738.
77. Liu, S.-H.; Hamilton, A. D. Rapid and highly base selective RNA cleavage by a dinuclear Cu(II) complex. Chem. Commun., 1999, (7), 587-588.
78. Uma, V.; Elango, M.; Nair, B. U. Copper(II) terpyridine complexes: effect of substituent on DNA binding and nuclease activity. Eur. J. Inorg. Chem., 2007, (22), 3484-3490.
79. Köpf-Maier, P. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma. Anticancer Res., 1999, 19(1), 493-504.
80. Jaouen, G.; Top, S.; Vessieres, A.; Leclerq, G.; McGlinchey, M. J. The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer. Curr. Med. Chem., 2004, 11(18), 2505-2517.
81. Peacock, A. F. A.; Sadler, P. J. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents. Chem. Asian J., 2008, 3(11), 1890-1899.
82. Bergamo, A.; Sava, G. Ruthenium complexes can target determinants of tumour malignancy. Dalton Trans. 2007, (13), 1267-1272.
83. Allardyce, C. S.; Dorcier, A.; Scolaro, C.; Dyson, P. J. Development of organometallic (organo-transition metal) pharmaceuticals. Appl. Organomet. Chem., 2005, 19(1), 1-10.
84. Hartinger, C. G.; Dyson, P. J. Bioorganomet-aletal/et-allic chemistry - from teaching paradigms to medicinal applications. Chem. Soc. Rev., 2009, 38(2), 391-401.
85. Van Staveren, D. R.; Metzler-Nolte, N. Bioorganometallic chemistry of ferrocene. Chem. Rev., 2004, 104(102), 5931-5986.
86. Fouda, M. F. R.; Abd-El-Zaher, M. M.; Abd-El-Samaia, R. A.; Labib, A. A. On the medicinal chemistry of ferrocene. Appl. Organomet. Chem., 2007, 21(8), 613-625.
87. Swarts, J. C.; Vosloo, T. G.; Cronje, S. J.; Du Plessis, W. C.; van Rensburg, C. E. J.; Kreft, E.; Van Lier, J. E. Cytotoxicity of a series of ferrocene-containing β-diketones. Anticancer Res., 2008, 28(5A), 2781-2784.
88. Tabbì, G.; Cassino, C.; Cavigiolio, G.; Colangelo, D.; Ghilia, A.; Viano, I.; Osella, D. Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives: ESR insights on the radical production during the degradation process. J. Med. Chem., 2002, 45(26), 5786-5796.
89. Osella, D.; Ferrali, M.; Zanello, P.; Laschi, F.; Fontani, M.; Nervi, C.; Cavigiolio, G. On the mechanism of the antitumor activity of ferrocenium derivatives. Inorg. Chim. Acta, 2000, 306(1), 42-48.
90. Maity, B.; Roy, M.; Banik, B.; Majumdar, R.; Dighe, R. R.; Chakravarty, A. R. Ferrocene-promoted photoactivated DNA cleavage and anticancer activity of terpyridyl copper(II) phenanthroline complexes. Organometallics, 2010, 29(16), 3632-3641.
91. Neyhart, G. A.; Grover, N.; Smith, S. R.; Kalsbeck, W. A.; Fairley, T. A.; Cory, M.; Thorp, H. H. Binding and kinetics studies of oxidation of DNA by oxoruthenium(IV). J. Am. Chem. Soc., 1993, 115 4423-4428.
92. Van der Schilden, K.; Garcìa, F.; Kooijman, H.; Spek, A. L.; Haasnoot, J. G.; Reedijk, J. A highly flexible dinuclear ruthenium(II)-platinum(II) complex: crystal structure and binding to 9-ethylguanine. Angew. Chem. Int. Ed., 2004, 43(42), 5668-5670.
93. Van der Steen, S.; De Hoog, P.; Van der Schilden, K.; Gamez, P.; Pietié, M.; Kiss, R.; Reedijk, J. Novel heteronuclear rutheniumcopper coordination compounds as efficient DNA-cleaving agents. Chem. Commun., 2010, 46(20), 3568-3570.
94. Mir, L. M.; Tounekti, O.; Orlowski, S. Bleomycin: revival of an old drug. Gen. Pharmacol., 1996, 27(5), 745-748.
95. Umezawa, H. Bleomycin and other antitumor antibiotics of high molecular weight. Antimicrob. Agents Chemother., 1965, 5(1), 1079-1085.
96. Claussen, C. A.; Long, E. C. Nucleic acid recognition by metal complexes of bleomycin. Chem. Rev., 1999, 99(9), 2797-2816.
97. Wong, E. L.-M.; Fang, G.-S.; Che, C.-M.; Zhu, N.-Y. Highly cytotoxic iron(II) complexes with pentadentate pyridyl ligands as a new class of anti-tumor agents. Chem. Commun., 2005, (36), 4578-4580.
98. Ware, D. C.; Brothers, P. J.; Clark, G. R.; Denny, W. A.; Palmer, B. D.; Wilson, W. R. Synthesis, structures and hypoxia-selective cytotoxicity of cobalt(III) complexes containing tridentate amine and nitrogen mustard ligands. J. Chem. Soc., Dalton Trans., 2000, (6), 925-932.
99. Blower, P. J.; Dilworth, J. R.; Maurer, R. I.; Mullen, G. D.; Reynolds, C. A.; Zheng, Y.-F. Towards new transition metal-based hypoxic selective agents for therapy and imaging. J. Inorg. Biochem., 2001, 85(1), 15-22.
100. Bonnitcha, P. D.; Hall, M. D.; Underwood, C. K.; Foran, G. J.; Zhang, M.; Beale, P. J.; Hambley, T. W. XANES investigation of the Co oxidation state in solution and in cancer cells treated with Co(III) complexes. J. Inorg. Biochem., 2006, 100(5-6), 963-971.
101. Jin, L.; Yang, P. Synthesis and DNA binding studies of CoIII mixed-ligand complex containing dipyrido [3,2-a: 2',3'-c]phenazine and phen. Polyhedron, 1997, 16(19), 3395-3398.
102. Arounaguiri, S.; Maiya, B. G. Dipyridophenazine complexes of cobalt(III) and nickel(II): DNA-binding and photocleavage studies. Inorg. Chem., 1996, 35(14), 4267-4270.
103. Indumathy, R.; Kanthimathi, M.; Weyhermüller, T.; Nair, B. U. Cobalt complexes of terpyridine ligands: crystal structure and nuclease activity. Polyhedron, 2008, 27(17), 3443-3450.
104. Indumathy, R.; Radhika, S.; Kanthimathi, M.; Weyhermüller, T.; Nair, B. U. Cobalt complexes of terpyridine ligand: crystal structure and photocleavage of DNA. J. Inorg. Biochem., 2007, 101(3), 434-443.
105. Shrinivastava, H. Y.; Kanthimathi, M.; Nair, B. U. Interaction of Schiff base with bovine serum albumin: site-specific photocleavage. Biochem. Biophys. Res. Commun., 1999, 265(2), 311-314.
106. 2++-mediated Fenton reactions has possible biological implications. J. Biol. Chem., 1999, 274(2), 962-971.
107. Raja, N. S.; Nair, B. U. Chromium(III) complexes inhibit transcription factors binding to DNA and associated gene expression. Toxicology, 2008, 251(1-3), 61-65.
108. Vaidyanathan, V. G.; Nair, B. U. Nucleobase oxidation of DNA by (terpyridyl)chromium(III) derivatives. Eur. J. Inorg. Chem., 2004, (9), 1840-1846.
109. Kwong, D. W.-J.; Chan, O.-Y.; Wong, R. N.-S.; Musser, S. M.; Vaca, L.; Chan, S. I. DNA-photocleavage activities of vanadium(V)-peroxo complexes. Inorg. Chem., 1997, 36(7), 1276-1277.
110. Djordjevic, C.; Wampler, G. L. Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium. J. Inorg. Chem., 1985, 25(1), 51-55.
111. 2(phen)]. Biochemistry, 1996, 35(38), 12354-12362.
112. Lo, K. K.-W.; Chung, C.-K.; Ng, D. C.-M.; Zhu, N. Syntheses, characterisation and photophysical studies of novel biological labelling reagents derived from luminescent iridium(III) terpyridine complexes. New J. Chem., 2002, 26(1), 81-88.
113. Batey, R. T.; Rambo, R. P.; Doudna, J. A. Tertiary motifs in RNA structure and folding. Angew. Chem. Int. Ed., 1999, 38(16), 2326-2343.
114. Bianké, G.; Häner, R. A metal-coordinating DNA hairpin mimic. ChemBioChem 2004, 5(8), 1063-1068.
115. Yang, H.; Rys, A. S.; McLaughlin, C. K.; Sleiman, H. F. Templated ligand environments for the selective incorporation of different metals into DNA. Angew. Chem. Int. Ed., 2009, 48(52), 9919-9923.
116. Vandermeulen, G. W. M.; Tziatzios, C.; Schubert, D.; Andres, P. R.; Schubert, U. S.; Klok, H.-A. Metalion assisted folding and supramolecular organization of a de novo designed metalloprotein. Aust. J. Chem., 2004, 57(1), 33-39.
117. Thordarson, P.; Le Droumaguet, B.; Velonia, K. Well-defined protein-polymer conjugates - synthesis and potential applications. Appl. Microbiol. Biotechnol., 2006, 73(2), 243-254.
118. Velonia, K. Protein-polymer amphiphilic chimeras: recent advances and future challenges. Polym. Chem., 2010, 1(7), 944-952.
119. Velonia, K.; Thordarson, P.; Andres, P. R.; Schubert, U. S.; Rowan, A. E.; Nolte, R. J. M. Polymer-protein giant amphiphiles by metal-to-ligand coordination. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem., 2003, 44(1), 648-649.
120. Velonia, K.; Thordarson, P.; Schubert, U. S.; Rowan, A. E.; Nolte, R. J. M. Bio-hybrid giant amphiphiles by metal-to-ligand coordination. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 2004, 45(2), 401-402.
121. Velonia, K.; Rowan, A. E.; Nolte, R. J. M. Lipase polystyrene giant amphiphiles. J. Am. Chem. Soc., 2002, 124(16), 4224-4225.
122. Peterson, J. R.; Thordarson, P. Optimising the purification of terpyridine-cytochrome c bioconjugates. Chiang Mai J. Sci., 2009, 36(2), 236-246.
123. Peterson, J. R.; Smith, T. A.; Thordarson, P. Photoinduced reduction of catalytically and biologically active Ru(II)-bisterpyridine-cytochrome c bioconjugates. Chem. Commun., 2007, (19), 1899-1901.
124. Peterson, J. R.; Smith, T. A.; Thordarson, P. Synthesis and room temperature photo-induced electron transfer in biologically active bis(terpyridine)ruthenium(II)-cytochrome c bioconjugates and the effect of solvents on the bioconjugation of cytochrome c. Org. Biomol. Chem., 2010, 8(1), 151-162.
125. Hofmeier, H.; Pahnke, J.; Weidl, C. H.; Schubert, U. S. Combined biotin-terpyridine systems: a new versatile bridge between biology, polymer science and metallo-supramolecular chemistry. Biomacromolecules, 2004, 5(5), 2055-2064.
126. Ma, D.-L.; Shum, T. Y.-T.; Zhang, F.-Y.; Che, C.-M.; Yang, M.-S. Water soluble luminescent platinum terpyridine complexes with glycosylated acetylide and arylacetylide ligands: Photoluminescent properties and cytotoxicities. Chem. Commun., 2005, 37, 4675-4677.
127. Constable, E. C.; Mundwiler, S. Metal-ion control of molecular recognition - sugar-functionalised 2,2':6',2'-terpyridines. Polyhedron, 1999, 18(18), 2433-2444.
128. Constable, E. C.; Kariuki, B. M.; Mahmood, A. New approaches to sugar-functionalised 2,2':6',2'-terpyridines based upon tetrafluorophenoxy spacers: crystal and molecular structures of 4'-(tetrafluoro-4-hydroxyphenyl)-2,2':6',2'-terpyridine and 4'-(4-methoxytetrafluorophenyl)-2,2':6',2'-terpyridine. Polyhedron, 2003, 22(1), 687-698.